Acomplia Weight Loss Is Short Term

May 29th, 2007

According to researchers, weight loss benefits achieved by taking diet drug Acomplia only kept if you continue taking the medication.

Patients who stay on the drug keep the weight off, the lower blood-fat levels, and higher good cholesterol levels.

Acomplia won’t help you lose weight if you don’t cut your calories but, in tests, those that did take it lost an average of 10.5 pounds more than those that didn’t.

Acomplia works by partially shutting down the system that gives you the “munchies”, helping people resist the craving for those highly palatable foods.

The drug also helps people quit smoking.

The FDA has not yet approved Acomplia, but is expected to act soon.

Zelnorm Recall: What are my alternatives?

May 16th, 2007

The FDA in the US recalled Zelnorm (tegaserod maleate), a prescription drug used to treat acute and chronic constipation, in March of 2007 after studies showed that a statistically significant number of cardiovascular problems occurred in patients taking Zelnorm. Constipation affects approximately 20 percent of the U.S. population and about 500,000 people in 2006 were prescribed Zelnorm.

One alternative to Zelnorm is Lactulose syrup. This over-the-counter item comes in 500mL bottles and is reasonably priced between $22-$25.

Prescription Drug Found to Help People Forget

November 29th, 2006

Can a pill help suppress traumatic memories?

If a prescription medication could permenantly dull your memory of painfull events, would you take it? In a piece for 60 minutes, correspondent Lesley Stahl reports that this idea isn’t too far off.

It was found that Propranolol, a prescription drug traditionally taken to treat hypertension and marketed under the name Inderal, can sit on certain nerve cells to act as a lock to block memories. The man who discovered this is James McGaugh, a professor of neurobiology at the University of California, Irvine.

McGaugh says that adrenalin helps the brain form memories, that’s why emotional events are more easily remembered than regular day-to-day occurences.

This finding could be a break-through for people affected by post traumatic stress disorder.

For the full story visit the CBS site.

Pharmacy Industry News: New Drug Launch - Nuvigil

November 22nd, 2006

Cephalon Inc., the manufacturer of one of’s biggest sellers Provigil, have just received a patent for their new formulation for the active ingredient and manufacturing of armodafinil. Armodafinil is the active ingredient for Frazer, Pa based Cephalon’s soon to be launched product Nuvigil, which is intended to be an improved version of their top-selling product Provigil.

The FDA provided Cephalon with an approvable letter this past May for Nuvigil. They are still waiting for for full approval. We will keep you updated with future changes.